Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Abstract

Objective: To provide an overview of the hematopoietic stem cell transplantation (HSCT) process specific to patients with multiple myeloma (MM) and their caregivers.

Data sources: Research studies, book chapters, websites, expert knowledge, and journal articles.

Conclusion: Although not curative, autologous HSCT is an important, manageable treatment modality, and continues to be a standard of care in MM for those patients who are eligible.

Implications for nursing practice: Although an area of specialty practice, an understanding of the HSCT process is important to broaden the knowledge of all nurses who care for patients with MM.

Keywords: caregivers; hematopoietic stem cell transplantation; multiple myeloma; resources; treatment.